Found: 6
Select item for more details and to access through your institution.
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E291, doi. 10.1002/ajh.25605
- By:
- Publication type:
- Article
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rapid Reduction of Peripheral Blasts in Older Patients with Refractory Acute Myeloid Leukemia (AML) Using Re-Induction with Single Agent Anti-CD45 Targeted Iodine (131I) Apamistamab [Iomab-B] Radioimmunotherapy in the Phase III SIERRA Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S232, doi. 10.1016/j.clml.2019.07.117
- By:
- Publication type:
- Article
Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1077, doi. 10.1111/bjh.18950
- By:
- Publication type:
- Article
Biosimilar strategic implementation at a large health system.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 4, p. 268, doi. 10.1093/ajhp/zxab410
- By:
- Publication type:
- Article